Prof. Dieter Deforce is Professor at the Faculty of Pharmaceutical Sciences, Ghent University, and Head of the Laboratory of Pharmaceutical Biotechnology. He obtained his MSc in Pharmaceutical Sciences at Ghent University in 1994 (magna cum laude) and his PhD in 1999. In the same year, he received BAEF and D. Collen Research Foundation fellowships for postdoctoral research at the University of California, San Diego (1999–2000), followed by an FWO postdoctoral fellowship in 2000.
Appointed professor in 2001, he took on extensive teaching responsibilities, built a research group, and established a major forensic DNA analysis service. He was responsible for an accredited Forensic DNA Laboratory and co-founded the Forensic Institute Ghent. In 2016, routine forensic activities were spun out through collaboration with Eurofins Forensics Belgium. He remains active as a forensic DNA expert, while forensic research continues within his academic group.
He is Chair of the Belgian Medicines Committee, a member of the Scientific Advice Working Party of the European Medicines Agency, and since 2023 Chairperson of the AUGent IOF. He is a partner in NXTGNT, Director of the ProGenTomics core facility, a board member of VIB, and a member of VARIO. His research applies proteomics and genomics, including next-generation sequencing, in pharmacogenomics, stem cell research, prenatal diagnostics, (auto)immunity, and forensics. He has (co-)authored over 400 scientific publications.
Prof. Dieter Deforce is Professor at the Faculty of Pharmaceutical Sciences, Ghent University, and Head of the Laboratory of Pharmaceutical Biotechnology. He obtained his MSc in Pharmaceutical Sciences at Ghent University in 1994 (magna cum laude) and his PhD in 1999. In the same year, he received BAEF and D. Collen Research Foundation fellowships for postdoctoral research at the University of California, San Diego (1999–2000), followed by an FWO postdoctoral fellowship in 2000.
Appointed professor in 2001, he took on extensive teaching responsibilities, built a research group, and established a major forensic DNA analysis service. He was responsible for an accredited Forensic DNA Laboratory and co-founded the Forensic Institute Ghent. In 2016, routine forensic activities were spun out through collaboration with Eurofins Forensics Belgium. He remains active as a forensic DNA expert, while forensic research continues within his academic group.
He is Chair of the Belgian Medicines Committee, a member of the Scientific Advice Working Party of the European Medicines Agency, and since 2023 Chairperson of the AUGent IOF. He is a partner in NXTGNT, Director of the ProGenTomics core facility, a board member of VIB, and a member of VARIO. His research applies proteomics and genomics, including next-generation sequencing, in pharmacogenomics, stem cell research, prenatal diagnostics, (auto)immunity, and forensics. He has (co-)authored over 400 scientific publications.